Validation of Insulin-Like Growth Factor-1 as a Prognostic Parameter in Patients With Hepatocellular Carcinoma in a European Cohort

BMC Cancer- United Kingdom

doi 10.1186/s12885-018-4677-y

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

CTCs as a Prognostic Factor in Hepatocellular Carcinoma Patients and Liver Transplantation

HPB
HepatologyGastroenterology
2018English

Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Reactivation of the Insulin-Like Growth Factor-Ii Signaling Pathway in Human Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2008English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Vascular Endothelial Growth Factor as a Prognostic Parameter in Subjects With “Plateau Red Face”

High Altitude Medicine and Biology
Public HealthSports ScienceEnvironmentalMedicinePhysiologyOccupational Health
2015English

CBX8 Exhibits Oncogenic Properties and Serves as a Prognostic Factor in Hepatocellular Carcinoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Validation of a Model to Estimate Survival in Ambulatory Patients With Hepatocellular Carcinoma: A Single-Centre Cohort Study

Liver International
Hepatology
2014English

The Insulin-Like Growth Factor-1 and Expression of Its Binding Protein‑3 in Chronic Hepatitis C and Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2013English

In Situ Detection of Insulin-Like Growth Factor II ( IGF2 ) and H19 Gene Expression in Hepatocellular Carcinoma

Journal of Human Genetics
Genetics
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy